Omalizumab in severe asthma and food allergies with IgE levels >1500 kU /L: Two‐year evaluation
Pediatric Allergy and Immunology · 2023
DOI: 10.1111/pai.14057 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Allergy and Immunology, 2023. Verfasst von Giulio Dinardo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Woman, Child and of General and Specialized Surgery, University of Campania Luigi Vanvitelli, Naples, Italy. Hauptthemen laut MEDLINE: Asthma, Food Hypersensitivity, Anti-Asthmatic Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Woman, Child and of General and Specialized Surgery, University of Campania Luigi Vanvitelli, Naples, Italy.
- Allergy Diseases Research Area, Pediatric Allergology Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
- Department of Human Pathology in Adult and Developmental Age 'Gaetano Barresi', Pediatric Unit, University of Messina, Messina, Italy.
ORCID-Profile: Giulio Dinardo, Francesca Galletta, Alessandro Fiocchi, Stefania Arasi
Zitieren
APA
Dinardo, G., Cafarotti, A., Galletta, F., Fiocchi, A., & Arasi, S. (2023). Omalizumab in severe asthma and food allergies with IgE levels >1500 kU /L: Two‐year evaluation. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.14057
Vancouver
Dinardo G, Cafarotti A, Galletta F, Fiocchi A, Arasi S. Omalizumab in severe asthma and food allergies with IgE levels >1500 kU /L: Two‐year evaluation. Pediatric Allergy and Immunology. 2023. doi:10.1111/pai.14057
BibTeX
@article{Dinardo2023,
author = {Dinardo, Giulio and Cafarotti, Arianna and Galletta, Francesca and Fiocchi, Alessandro and Arasi, Stefania},
title = {Omalizumab in severe asthma and food allergies with IgE levels >1500 kU /L: Two‐year evaluation},
journal = {Pediatric Allergy and Immunology},
year = {2023},
doi = {10.1111/pai.14057}
}
EUVIMED